NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

RNAseq: RNA Sequencing (IDT) Analytical Validation (MD Anderson   Add to my SOP compendium

BRD ID: 3,444

Source: CIMAC-CIDC Network Tier: SOP Number of times downloaded: 61

Description

This analytical validation and performance report describes the methods used to validate the IDT xGen Library preparation kit with the xGen Exome Hyb Panel V2 exome capture RNA sequencing assay. Sensitivity and precision were assessed using Seraseq® reference materials. Specificity was evaluated using FFPE specimens from healthy individuals and tumor specimens. Accuracy was assessed by comparing results obtained for 54 FFPE specimens with those obtained using Nanostring’s nCounter® PanCancer Immune Profiling Panel. It is used by the Cancer Immune Monitoring and Analysis Center (CIMAC) at MD Anderson Cancer Center. It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/research/networks/precision-medicine-oncology/cimac-cidc).

Documents for Download

MDACC RNA Sequencing Analytical Validation_IDT.pdf [Size: 2818 KB]

Biospecimens
  • Tissue - General
  • Tissue - Not specified
  • Cell - Blood
Diagnoses
  • Not specified
  • General
  • Neoplastic - Carcinoma
  • Neoplastic - Not specified
Topics
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • 2025’s Most Popular SOPs: See What Users Downloaded Most

  • Improving RNAseq Analysis of Small Biospecimens: New Recommendations Available

  • 2026 NCI Best Practices for Biospecimen Resources is Now Available!

  • More...